newsfilter
← Latest News
GlobeNewswire·

Aclaris Therapeutics to Participate in Two March Healthcare Conferences

WAYNE, Pa., March 04, 2025 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ:ACRS), a clinical-stage biopharmaceutical company focused on developing novel product candidates for immuno-inflammatory diseases, today